AU2001271926A1 - Methods for promoting dendritic cell proliferation or differentiation - Google Patents
Methods for promoting dendritic cell proliferation or differentiationInfo
- Publication number
- AU2001271926A1 AU2001271926A1 AU2001271926A AU7192601A AU2001271926A1 AU 2001271926 A1 AU2001271926 A1 AU 2001271926A1 AU 2001271926 A AU2001271926 A AU 2001271926A AU 7192601 A AU7192601 A AU 7192601A AU 2001271926 A1 AU2001271926 A1 AU 2001271926A1
- Authority
- AU
- Australia
- Prior art keywords
- differentiation
- methods
- cell proliferation
- dendritic cell
- promoting dendritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000024245 cell differentiation Effects 0.000 title 1
- 230000004663 cell proliferation Effects 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/32—Angiotensins [AT], angiotensinogen
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21795100P | 2000-07-13 | 2000-07-13 | |
US60/217,951 | 2000-07-13 | ||
PCT/US2001/021587 WO2002006308A2 (en) | 2000-07-13 | 2001-07-09 | Methods for promoting dendritic cell proliferation or differentiation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271926A1 true AU2001271926A1 (en) | 2002-01-30 |
Family
ID=22813145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271926A Abandoned AU2001271926A1 (en) | 2000-07-13 | 2001-07-09 | Methods for promoting dendritic cell proliferation or differentiation |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020165141A1 (en) |
AU (1) | AU2001271926A1 (en) |
WO (1) | WO2002006308A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003217783A1 (en) * | 2002-02-27 | 2003-09-09 | Wake Forest University | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
US7335686B2 (en) * | 2003-10-20 | 2008-02-26 | Council Of Scientific And Industrial Research | Method and composition for treating osteoporosis |
EP1944361A1 (en) * | 2007-01-11 | 2008-07-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A method for expanding monocytes |
AT508569A1 (en) * | 2009-07-23 | 2011-02-15 | Affiris Ag | PHARMACEUTICAL COMPOUND |
WO2011053789A2 (en) * | 2009-10-30 | 2011-05-05 | James Cameron Oliver | Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease |
US20140205631A1 (en) * | 2013-01-23 | 2014-07-24 | University Of Southern California | Stimulation of vaccination by angiotensin peptides |
AU2014284496A1 (en) | 2013-07-03 | 2016-01-21 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for treating cognitive dysfunction |
US10183055B2 (en) | 2014-07-21 | 2019-01-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications |
JP6666899B2 (en) | 2014-07-21 | 2020-03-18 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニヴァーシティー オブ アリゾナ | ANG- (1-7) derivative oligopeptides and methods for using and making them |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002503702A (en) * | 1998-02-19 | 2002-02-05 | ユニヴァースティ オブ サザーン カリフォルニア | Method for promoting cell proliferation and differentiation of nerve cells |
-
2001
- 2001-07-09 US US09/900,936 patent/US20020165141A1/en not_active Abandoned
- 2001-07-09 WO PCT/US2001/021587 patent/WO2002006308A2/en active Application Filing
- 2001-07-09 AU AU2001271926A patent/AU2001271926A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002006308A3 (en) | 2003-02-27 |
US20020165141A1 (en) | 2002-11-07 |
WO2002006308A2 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001272928A1 (en) | Distribution system | |
AU2002357049A1 (en) | Methods for preparing 0-desmethylvenlafaxine | |
EP1130098A3 (en) | Mammalian osteoregulins | |
AU5170900A (en) | Cell proliferation inhibitors | |
AU2002249531A1 (en) | Immunotherapy based on dendritic cells | |
AU1854901A (en) | Novel method | |
AU4977800A (en) | (in situ) forming hydrogels | |
WO2002087504A9 (en) | Methods for inhibiting tumor cell proliferation | |
AU4697600A (en) | Methods for increasing t cell proliferation | |
AU2001271926A1 (en) | Methods for promoting dendritic cell proliferation or differentiation | |
AU2002323690A1 (en) | Systems and methods for weighing and charging | |
AU3583000A (en) | Method for direct steelmaking | |
AU2002365938A1 (en) | Modified antigen-presenting cells | |
AU2001240557A1 (en) | Implant for cranioplastics | |
AU2001227395A1 (en) | Block system | |
AUPQ314799A0 (en) | Bone cell factor | |
AU5849300A (en) | Proliferation differentiation factor | |
AU2002257064A1 (en) | Methods for isolating proteins expressed by dendritic cells | |
AU5533699A (en) | Endothelial cell proliferation inhibitors derived from human prothrombin | |
AU3710801A (en) | Distribution system | |
AU7121000A (en) | Method for parallel polymerization | |
AU2002224357A1 (en) | Mammalian wnt polypeptide-5 | |
AU2113700A (en) | Method for increasing the efficiency in trade | |
AU5622201A (en) | Method for isolating in vitro differentiated somatic cells | |
AU6004200A (en) | Process for innocuating an element in steel |